Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 15;24(12):10167.
doi: 10.3390/ijms241210167.

The Role of Diabetic Choroidopathy in the Pathogenesis and Progression of Diabetic Retinopathy

Affiliations
Review

The Role of Diabetic Choroidopathy in the Pathogenesis and Progression of Diabetic Retinopathy

Luca Scuderi et al. Int J Mol Sci. .

Abstract

Diabetic choroidopathy was first described on histopathological specimens of diabetic eyes. This alteration was characterized by the accumulation of PAS-positive material within the intracapillary stroma. Inflammation and polymorphonuclear neutrophils (PMNs) activation are crucial elements in choriocapillaris impairment. The evidence of diabetic choroidopathy in vivo was confirmed with multimodal imaging, which provides key quantitative and qualitative features to characterize the choroidal involvement. The choroid can be virtually affected in each vascular layer, from Haller's layer to the choriocapillaris. However, the damage on the outer retina and photoreceptor cells is essentially driven by a choriocapillaris deficiency, which can be assessed through optical coherence tomography angiography (OCTA). The identification of characteristic features of diabetic choroidopathy can be significant for understanding the potential pathogenic and prognostic implications in diabetic retinopathy.

Keywords: choriocapillaris; choroid; diabetes mellitus; diabetic choroidopathy; diabetic retinopathy; optical coherence tomography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Østergaard J., Hansen T.K., Thiel S., Flyvbjerg A. Complement activation and diabetic vascular complications. Clin. Chim. Acta. 2005;361:10–19. doi: 10.1016/j.cccn.2005.04.028. - DOI - PubMed
    1. Banson B.B., Lacy P.E. Diabetic microangiopathy in human toes; With emphasis on the ultrastuctural change in dermal capillaries. Am. J. Pathol. 1964;45:41–58. - PMC - PubMed
    1. Feher J., Taurone S., Spoletini M., Biro Z., Varsanyi B., Scuderi G., Orlando M.P., Turchetta R., Micera A., Artico M. Ultrastructure of neurovascular changes in human diabetic retinopathy. Int. J. Immunopathol. Pharmacol. 2018;31:394632017748841. doi: 10.1177/0394632017748841. - DOI - PMC - PubMed
    1. Simo R., Simo-Servat O., Bogdanov P., Hernandez C. Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy. Pharmaceutics. 2021;13:1320. doi: 10.3390/pharmaceutics13081320. - DOI - PMC - PubMed
    1. Antonetti D.A., Klein R., Gardner T.W. Diabetic retinopathy. N. Engl. J. Med. 2012;366:1227–1239. doi: 10.1056/NEJMra1005073. - DOI - PubMed

MeSH terms